Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis

To affirm the short-term safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among people with multiple sclerosis (pwMS), 517 vaccinated and 174 unvaccinated pwMS were interviewed. 16.2% of the vaccinated pwMS reported at least one neurological symptom in their respective vaccine-related at-risk p...

Descripción completa

Detalles Bibliográficos
Autores principales: Etemadifar, Masoud, Abhari, Amir Parsa, Nouri, Hosein, Sigari, Amirhossein Akhavan, Piran Daliyeh, Seyed Mohammad, Maracy, Mohammad Reza, Salari, Mehri, Maleki, Shiva, Sedaghat, Nahad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009900/
https://www.ncbi.nlm.nih.gov/pubmed/35201963
http://dx.doi.org/10.1080/21645515.2022.2041945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009900/
https://www.ncbi.nlm.nih.gov/pubmed/35201963
http://dx.doi.org/10.1080/21645515.2022.2041945

Ejemplares similares